| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.091 | 0.09 |
| mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | -0.057 | 0.09 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.09 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | -0.056 | 0.09 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.09 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | 0.1 | 0.09 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | 0.063 | 0.09 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.063 | 0.09 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.066 | 0.1 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | 0.061 | 0.1 |